Transcarotid Artery Revascularization (TCAR)
Groundbreaking Technology for Carotid Artery Disease
Every year, 15 million people worldwide suffer a stroke, also known as a brain attack. Nearly 6 million die, and another 5 million are left permanently disabled. Carotid artery disease is the cause of stroke in up to a third of cases.
Powers Health offers minimally invasive TransCarotid Artery Revascularization (TCAR) to treat carotid artery disease and prevent future strokes.
TCAR is a clinically proven treatment that utilizes temporary blood flow reversal during direct, transcarotid stent placement. This treatment option provides best-in-class neuroprotection in a more efficient and less invasive approach compared to traditional carotid endarterectomy.
Carotid artery disease is a form of atherosclerosis, or a build-up of plaque, in the two main arteries in the neck that supply oxygen-rich blood to the brain.
The TCAR procedure involves direct access to the carotid artery through a small incision just above the clavicle – creating just enough room to place a stent directly into the carotid artery to stabilize the blockage. This minimally invasive procedure is unique in that blood flow is temporarily reversed so any small bits of plaque that may break off are diverted away from the brain, preventing a stroke from happening.
Benefits to TCAR compared to traditional carotid endarterectomy, a more invasive open surgery:
- Smaller incision and scarring
- Less recovery time
- Shorter hospital stays
- Lower risk of nerve injuries